Olympian to Run Marathon for Pediatric Cancer Support
Sheena Lawrick runs the NYC Marathon to support the cancer center that provided her son’s specialized care.
Updated on Oct. 30, 2026 in Cancer
Evanston resident and former Olympian Sheena Lawrick will participate in the 50th New York City Marathon on November 1, 2026. She is running as part of Fred's Team to support pediatric cancer research at Memorial Sloan Kettering Cancer Center.
Why it matters
Lawrick is highlighting the impact of pediatric cancer care in honor of her son, Gus, who was treated for retinoblastoma at age four. The effort underscores the importance of ongoing follow-up for survivors and the role of charitable support in cancer research.
Memorial Sloan Kettering Cancer Center reports a 99% cure rate and a 95% eye retention rate for retinoblastoma patients. These figures reflect institutional outcomes for children like six-year-old Gus, though patients require annual follow-up scans for life.
The players
Sheena Lawrick
An Evanston resident and former Olympic softball player who is raising funds for cancer research.
Memorial Sloan Kettering Cancer Center
A world-renowned institution specializing in advanced cancer treatment and pediatric research.
The details
Gus received a specialized treatment plan consisting of three intravitreal chemotherapy injections and three intra-arterial chemotherapy treatments. This approach delivers targeted medication directly to the eye, minimizing systemic exposure while managing the tumor. Lawrick, a two-time Olympic softball player for Team Canada, was selected for the marathon's Team Inspire to raise over $20,000 for these continued treatment efforts.
Timeline
February 2024: Lawrick and her wife consulted a pediatric ophthalmologist regarding their son.
November 1, 2026: Sheena Lawrick competes in the 50th New York City Marathon.
Health Landscape
Memorial Sloan Kettering Cancer Center's pediatric retinoblastoma program represents the current standard for eye-sparing treatment in pediatric oncology. The success of these protocols illustrates a shift toward targeted chemotherapy, reducing the need for more invasive procedures like eye removal.
Parents noticing changes in a child's vision or eye appearance should consult a pediatric ophthalmologist, as early detection is critical for successful retinoblastoma outcomes. Survivors of pediatric cancer should remain vigilant about maintaining their schedule of life-long follow-up scans.
The takeaway
The high success rates for childhood cancer treatment demonstrate the progress in pediatric oncology and the importance of timely intervention. Patients and families can track their ongoing health needs by staying consistent with recommended annual follow-up monitoring.
Further reading
For more information on current treatment options, visit the Cancer section.
Source note: This article includes information reported by Evanston RoundTable.
